These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 3574856)

  • 21. Central nervous system relapse in non-Hodgkin lymphoma. A single-center study of 532 patients.
    Bollen EL; Brouwer RE; Hamers S; Hermans J; Kluin M; Sankatsing SU; A-Tjak RV; Charvat MV; Kluin-Nelemans JC
    Arch Neurol; 1997 Jul; 54(7):854-9. PubMed ID: 9236574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-dose therapy and blood or marrow transplantation for non-Hodgkin lymphoma with central nervous system involvement.
    Kasamon YL; Jones RJ; Piantadosi S; Ambinder RF; Abrams RA; Borowitz MJ; Morrison C; Smith BD; Flinn IW
    Biol Blood Marrow Transplant; 2005 Feb; 11(2):93-100. PubMed ID: 15682069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improved survival rate in children with stage III and IV B cell non-Hodgkin's lymphoma and leukemia using multi-agent chemotherapy: results of a study of 114 children from the French Pediatric Oncology Society.
    Patte C; Philip T; Rodary C; Bernard A; Zucker JM; Bernard JL; Robert A; Rialland X; Benz-Lemoine E; Demeocq F
    J Clin Oncol; 1986 Aug; 4(8):1219-26. PubMed ID: 3525767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Central nervous system involvement in non-Hodgkin's lymphoma.
    Liang RH; Woo EK; Yu YL; Todd D; Chan TK; Ho FC; Tso SC; Shum JS
    Eur J Cancer Clin Oncol; 1989 Apr; 25(4):703-10. PubMed ID: 2714346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Four cases of central nervous system involvement of breast malignant lymphoma.
    Yamazaki H; Hanada M; Kitada M; Kuyama J; Sato T; Nishikubo M; Ishida T; Inoue T; Inoue T
    Jpn J Clin Oncol; 2003 Aug; 33(8):399-403. PubMed ID: 14523060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [NHL-BFM 90 therapy study in treatment of malignant non-Hodgkin's lymphomas in children and adolescents. Part 1: Classification and allocation to strategic therapy groups. BIF study group].
    Reiter A; Tiemann M; Ludwig WD; Wacker HH; Yakisan E; Schrappe M; Henzler D; Sykora KW; Brandt A; Odenwald E
    Klin Padiatr; 1994; 206(4):222-33. PubMed ID: 7967418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intensive chemotherapy without radiotherapy gives more than 85% event-free survival for non-Hodgkin lymphoma without central nervous involvement: a 6-year population-based study from the nordic society of pediatric hematology and oncology.
    Márky I; Björk O; Forestier E; Jónsson OG; Perkkiö M; Schmiegelow K; Storm-Mathiesen I; Gustafsson G;
    J Pediatr Hematol Oncol; 2004 Sep; 26(9):555-60. PubMed ID: 15342981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Non-Hodgkin's lymphomas in childhood. Evaluation of therapeutic results according to histopathologic criteria (Catalan Interhospital Group of Pediatric Oncology)].
    Cubells Riero J; Pardo García N; Turmo Martí J; Vela Ferrer E; Badía Torroella RM; González Rivero MA; Illa Sala J; Melo Valls M
    An Esp Pediatr; 1988 Sep; 29(3):203-7. PubMed ID: 3195869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-hodgkin's lymphoma in children. Correlation of CNS disease with initial presentation.
    Hutter JJ; Favara BE; Nelson M; Holton CP
    Cancer; 1975 Dec; 36(6):2132-7. PubMed ID: 1243106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Should intra-cerebrospinal fluid prophylaxis be part of initial therapy for patients with non-Hodgkin lymphoma: what we know, and how we can find out more.
    Herrlinger U; Glantz M; Schlegel U; Gisselbrecht C; Cavalli F
    Semin Oncol; 2009 Aug; 36(4 Suppl 2):S25-34. PubMed ID: 19660681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary non-Hodgkin's lymphomas of the central nervous system.
    Merkel KH; Hansmann ML
    Pathol Res Pract; 1986 Aug; 181(4):430-3. PubMed ID: 3532065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical significance of occult cerebrospinal fluid involvement assessed by flow cytometry in non-Hodgkin's lymphoma patients at high risk of central nervous system disease in the rituximab era.
    Sancho JM; Orfao A; Quijano S; García O; Panizo C; Pérez-Ceballos E; Deben G; Salar A; González-Barca E; Alonso N; García-Vela JA; Capote J; Peñalver FJ; Provencio M; Arias J; Plaza J; Caballero D; Morado M; Feliu E; Ribera JM;
    Eur J Haematol; 2010 Oct; 85(4):321-8. PubMed ID: 20528905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Central nervous system involvement in haematological malignancies.
    Sheehan T; Cuthbert RJ; Parker AC
    Clin Lab Haematol; 1989; 11(4):331-8. PubMed ID: 2605874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-Hodgkin's lymphoma involving the central nervous system.
    Wolf MM; Olver IN; Ding JC; Cooper IA; Liew KH; Madigan JP
    Aust N Z J Med; 1985 Feb; 15(1):16-21. PubMed ID: 3859259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Central nervous system involvement in T-cell lymphoma: A single center experience.
    Gurion R; Mehta N; Migliacci JC; Zelenetz A; Moskowitz A; Lunning M; Moskowitz C; Hamlin P; Horwitz S
    Acta Oncol; 2016 May; 55(5):561-6. PubMed ID: 27046135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Experience with results of treatment of non-Hodgkin's lymphoma].
    Gurzó M; Dobos K; Bérczi M; Varga G; Kelényi G
    Orv Hetil; 1992 May; 133(18):1091-7. PubMed ID: 1579348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. VACOP-B, high-dose cyclophosphamide and high-dose therapy with peripheral blood progenitor cell rescue for aggressive non-Hodgkin's lymphoma with bone marrow involvement: a study by the non-Hodgkin's Lymphoma Co-operative Study Group.
    Santini G; Coser P; Congiu AM; Salvagno L; De Souza C; Sertoli MR; Olivieri A; Chisesi T; Rubagotti A; Truini M; Contu A; Porcellini A; Zambaldi G; Nati S; Marino G; Rizzoli V
    Haematologica; 2000 Feb; 85(2):160-6. PubMed ID: 10681723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage--a report of the Berlin-Frankfurt-Münster Group.
    Reiter A; Schrappe M; Parwaresch R; Henze G; Müller-Weihrich S; Sauter S; Sykora KW; Ludwig WD; Gadner H; Riehm H
    J Clin Oncol; 1995 Feb; 13(2):359-72. PubMed ID: 7844597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinctive clinical features between lymphoblastic and immunoblastic non-Hodgkin's malignant lymphomas (Kiel's classification) in a series of 141 patients.
    Hoerni B; Trojani M; Eghbali H; Durand M; Coindre JM; Richaud P; Hoerni-Simon G; Lagarde C
    Hematol Oncol; 1983; 1(2):159-63. PubMed ID: 6689572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Non-Hodgkin's malignant lymphoma with central nervous involvement--report of 7 cases].
    Nagata T; Kobayashi A; Aiba K; Yokoyama K; Ikeda K; Kobayashi T; Chiene T; Kuraishi Y; Meguro S; Ichiba K; Abe M
    Gan No Rinsho; 1983 Jun; 29(7):838-42. PubMed ID: 6876452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.